The course is taught part-time, online, over two years.
The development and application of new health technologies is crucial to the future prosperity of both developed and developing nations. Health technology assessment (HTA), and the associated strategies for pricing technologies and obtaining reimbursement from purchasers, is a relatively new area of expertise.
From an industry perspective, the effective assessment, pricing and reimbursement techniques for health technologies are critical to bringing a technology to market and thus to corporate success. From the perspective of those charged with governing health technologies and reimbursing providers, evaluating the cost-effectiveness of health technologies is critical to equity and good governance of public monies.
The specific skills to undertake cost-effectiveness modelling, a key methodology within HTA, are highly technical and in high-demand within the pharmaceutical and healthcare industries. This course provides these skills. The online learning, part-time mode of delivery has been developed in response to a clear demand from the health technology industries, including pharmaceuticals, medical devices and diagnostic technologies.